Please click on an activity below to view a detailed description:
Supplements
Title Released Expires  
Considerations in Multiple Myeloma: Case Studies in Front-line Therapy2/17/20102/17/2011Activity Details
The 32nd Annual San Antonio Breast Cancer Symposium Highlights: A Payer's and Pharmacist's Perspective2/15/20102/15/2011Activity Details
Conference Faculty Perspectives: Highlights From ASH 20092/11/20102/11/2011Activity Details
New Treatments for Optimizing Bone Health in Patients With Multiple Myeloma: Proceedings From the Symposium Held at the IX International Meeting on Cancer-Induced Bone Disease2/11/20102/11/2011Activity Details
Multiple Myeloma and Health Economics: Highlights from the 2009 ASH Annual Meeting2/5/20102/5/2011Activity Details
Considerations in Non-Hodgkin's Lymphoma: Clinical Trial Updates2/2/20102/2/2011Activity Details
Value-Based Benefit Design
Workplace Wellness and Disease Prevention: Focus on Obesity
1/15/20101/15/2011Activity Details
Considerations in Non-Hodgkin's Lymphoma: T-Cell Lymphomas12/23/200912/23/2010Activity Details
New Directions in the Treatment of
Castration-Resistant Prostate Cancer
11/30/200911/30/2010Activity Details
Conference Faculty Perspectives:
Compendium From ASH, the XII International Myeloma Workshop, and the Pan Pacific Lymphoma Conference
11/16/200911/16/2010Activity Details
Considerations in Multiple Myeloma: Sequencing Strategies11/16/200911/16/2010Activity Details
Considerations in Multiple Myeloma:
To Transplant or Not to Transplant…That Is the Question!
11/16/200911/16/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Diffuse Large B-Cell Lymphoma11/6/200911/6/2010Activity Details
Advances in the Treatment of Non-Hodgkin's Lymphoma
Updates from the 2009 Pan Pacific Lymphoma Conference
10/30/200910/30/2010Activity Details
Conference Faculty Perspectives:
Updates From the Pan Pacific Lymphoma Conference
10/19/200910/19/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Waldenstrom’s Macroglobulinemia10/15/200910/15/2010Activity Details
Considerations in Multiple Myeloma: Cytogenetic Testing9/30/20099/30/2010Activity Details
Recent Advances in the Treatment of Multiple Myeloma9/30/20099/30/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Follicular Lymphoma9/21/20099/21/2010Activity Details
ASCO 2009 Highlights on Breast Cancer: A Payer's and Pharmacist's Perspective9/15/20099/15/2010Activity Details
Cutaneous and Peripheral T-Cell Lymphomas: The Latest in Treatment Advances and Management Strategies9/10/20099/10/2010Activity Details
Considerations in Multiple Myeloma: Stem Cell Mobilization8/31/20098/31/2010Activity Details
Metastatic Breast Cancer: Novel Agents and a Changing Treatment Paradigm8/31/20098/31/2010Activity Details
NCCN Updated Guidelines for Breast Cancer: A Payer's Perspective8/14/20098/14/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Mantle Cell Lymphoma8/10/20098/10/2010Activity Details
Workplace Wellness and Disease Prevention: Focus on Stroke8/3/20098/3/2010Activity Details
Recent Progress in the Management of Chronic Lymphocytic Leukemia7/31/20097/31/2010Activity Details
Considerations in Multiple Myeloma:
Perspectives on Relevant End Points of Clinical Trials
7/14/20097/14/2010Activity Details
Pharmaceutical Research & Development in a Value-Based Healthcare System6/30/20096/30/2010Activity Details
Value-Based Oncology Benefit Design™
Balancing Cost, Quality, and Access in Cancer Care
6/30/20096/30/2010Activity Details
Conference Faculty Perspectives:
Interpreting Key Multiple Myeloma Data from
the XII International Myeloma Workshop
6/29/20096/29/2010Activity Details
Balancing Cost, Quality, and Access in Chronic Myelogenous Leukemia Treatment6/22/20096/22/2010Activity Details
Considerations in Multiple Myeloma:
Do Complete Responses Correlate with Clinical Benefit?
6/10/20096/10/2010Activity Details
New Directions in the Treatment of Chemotherapy-Induced Nausea and Vomiting5/29/20095/29/2010Activity Details
Considerations in Multiple Myeloma: Maintenance Therapy5/11/20095/11/2010Activity Details
Health Economics in the Treatment of Multiple Myeloma:
Highlights from Recent Oncology Meetings
5/1/20095/1/2010Activity Details
Advances in Treatment Options for Patients With Myelodysplastic Syndromes4/30/20094/30/2010Activity Details
Conference Faculty Perspectives:
Interpreting Key Multiple Myeloma Data From ASH 2008
4/30/20094/30/2010Activity Details
Value-Based Oncology Benefit Design: Cost, Quality, and
Access Considerations in Colorectal Cancer Care
4/30/20094/30/2010Activity Details
Considerations in Multiple Myeloma: Retreatment Settings3/31/20093/31/2010Activity Details
Online
Title Released Expires  
Risk Evaluation and Mitigation Strategy (REMS): Implications, Opportunities and Learnings for All Medical Professionals2/9/20102/9/2011Activity Details
Metastatic Colorectal Cancer: Sound Strategies for Selecting First-Line Therapies11/25/200911/24/2010Activity Details
Conference Faculty Perspectives:
Compendium From ASH, the XII International Myeloma Workshop, and the Pan Pacific Lymphoma Conference
11/16/200911/16/2010Activity Details
Considerations in Multiple Myeloma: Sequencing Strategies11/16/200911/16/2010Activity Details
Considerations in Multiple Myeloma:
To Transplant or Not to Transplant…That Is the Question!
11/16/200911/16/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Diffuse Large B-Cell Lymphoma11/6/200911/6/2010Activity Details
Conference Faculty Perspectives:
Updates From the Pan Pacific Lymphoma Conference
10/19/200910/19/2010Activity Details
Considerations in Multiple Myeloma: Cytogenetic Testing9/30/20099/30/2010Activity Details
Recent Advances in the Treatment of Multiple Myeloma9/30/20099/30/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Follicular Lymphoma9/21/20099/21/2010Activity Details
Considerations in Multiple Myeloma: Stem Cell Mobilization8/31/20098/31/2010Activity Details
Considerations in Non-Hodgkin's Lymphoma: Mantle Cell Lymphoma8/10/20098/10/2010Activity Details
Considerations in Multiple Myeloma:
Perspectives on Relevant End Points of Clinical Trials
7/14/20097/14/2010Activity Details
Conference Faculty Perspectives:
Interpreting Key Multiple Myeloma Data from
the XII International Myeloma Workshop
6/29/20096/29/2010Activity Details
Considerations in Multiple Myeloma:
Do Complete Responses Correlate with Clinical Benefit?
6/10/20096/10/2010Activity Details
Considerations in Multiple Myeloma: Maintenance Therapy5/11/20095/11/2010Activity Details
Health Economics in the Treatment of Multiple Myeloma:
Highlights from Recent Oncology Meetings
5/1/20095/1/2010Activity Details
Conference Faculty Perspectives:
Interpreting Key Multiple Myeloma Data From ASH 2008
4/30/20094/30/2010Activity Details
Considerations in Multiple Myeloma: Retreatment Settings3/31/20093/31/2010Activity Details
Past Activities
Title Format Expired  
Angiogenesis Inhibition in the Fight Against CancerPrint2/27/2010Activity Details
Value-Based Oncology Benefit Design:
Breast Cancer, Multiple Myeloma, and Prostate Cancer
Print2/20/2010Activity Details
Current and Future Perspectives on the Treatment of Lung CancerPrint12/18/2009Activity Details
Colorectal Cancer Update: New Strategies in Supportive CarePrint12/9/2009Activity Details
Addressing Clinical Challenges in the Treatment of LeukemiaPrint11/25/2009Activity Details
Considerations in Multiple Myeloma: Side Effect ManagementOnline11/24/2009Activity Details
Considerations in Multiple Myeloma: Side Effect ManagementPrint11/24/2009Activity Details
Considerations in Multiple Myeloma: Health EconomicsOnline10/31/2009Activity Details
Considerations in Multiple Myeloma: Health EconomicsPrint10/31/2009Activity Details
Current and Future Perspectives on the Treatment of
Cutaneous T-cell Lymphoma and Peripheral T-cell Lymphoma
Print10/31/2009Activity Details
Developments in Metastatic Breast Cancer:
Incorporating Novel Agents into the Treatment Paradigm
Print10/31/2009Activity Details
Current and Future Perspectives on the Treatment of Colorectal CancerPrint10/27/2009Activity Details
Recent Regulatory Changes in the Cough/Cold MarketPrint10/17/2009Activity Details
New Therapeutic Approaches to Metastatic MelanomaPrint9/22/2009Activity Details
Effective Management Strategies for Skin Toxicities Associated with Epidermal Growth Factor Receptor (EGFR)-Inhibitor TherapyPrint9/19/2009Activity Details
Considerations in Multiple Myeloma: Hard-to-Treat PatientsOnline8/29/2009Activity Details
Considerations in Multiple Myeloma: Hard-to-Treat PatientsPrint8/29/2009Activity Details
Emerging Therapies for Myelodysplastic SyndromesPrint8/29/2009Activity Details
Considerations in Multiple Myeloma: Treatment-Naïve PatientsOnline7/31/2009Activity Details
Considerations in Multiple Myeloma: Treatment-Naïve PatientsPrint7/31/2009Activity Details
Front-Line Therapy for Multiple Myeloma:
Proceedings From a Roundtable Conference Incorporating Data
from ASH 2007
Online7/3/2009Activity Details
Front-Line Therapy for Multiple Myeloma:
Proceedings From a Roundtable Conference Incorporating Data
from ASH 2007
Print5/25/2009Activity Details
Considerations in Multiple Myeloma: Renal DysfunctionOnline5/7/2009Activity Details
Considerations in Multiple Myeloma: Renal DysfunctionPrint5/7/2009Activity Details